Panelists discuss how EGFR-targeted therapies differ in administration protocols and management strategies, with Palmer sharing tailored nursing interventions for oral tyrosine kinase inhibitors (TKIs ...

Panelists discuss how dermatologic toxicities from EGFR-targeted therapies can be effectively managed through a comprehensive approach combining prophylactic measures, early interventions with oral ...

The antibody-drug conjugate showed a higher objective response rate but failed to meet the primary OS endpoint in patients ...

"When most people hear the words palliative care, they immediately think about hospice or end-of-life care. This includes ...

Oncology nurses can educate patients about the potential indications for oncolytic virus therapy and connect them to ...

Here are the top 5 articles from 2024 reported on Oncology Nursing News. Opinion: The Media May Have Oversold AOH1996, City ...

The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of ...

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's ...

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's ...

Treatment sequencing with targeted therapies may help to improve overall survival, according to real-world data.

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...

Medical experts discuss strategies for patient education on managing potential adverse events of lorlatinib and other ALK ...